Earlier this month, the FDA’s Center for Biologics Evaluation and Research issued its highly anticipated guidance outlining the agency’s current thinking on granting emergency use authorization (EUA) to investigational vaccines for COVID-19.

As both an elected official and a conflict resolution specialist, many of the events of 2020 have deeply saddened me. It seems as if there is greater polarization in our country on the eve of our national election. On the neighborhood level, however, I would argue not a lot has changed.

This 29th edition of Unprecedented, our weekly update on COVID-19-related litigation, covers some of the hottest topics in these developing areas of law: governments' authority to implement mass gathering restrictions, face covering requirements, and curfews; personal injury and wrongful death cl

As we reported in our July 7, 2020 blog post on the USPTO v. Booking.com B.V decision, the U.S.